Investment Highlights

Disruptive MedTech Solution

  • Therapnea™ is a novel, patented technology to treat Obstructive Sleep Apnea (OSA)
  • Successful Proof of Concept clinical trial
  • Greatly improves patient health, experience & lifestyle

Experienced Team

  • 50 combined years of experience in the sleep related fields & decades of experience in MedTech and government regulations
  • Serial entrepreneurs with track record of successful exits
  • The company has raised $2.24M to date
  • Uniquely qualified Scientific Advisory Board with experience in clinical product development

Untapped Global Market

  • Large global market looking for a new solution
  • Life-threatening chronic sleep condition affects 12% of adults¹
  • Competing technology (CPAP) is 40+ years old with up to 50% of patients intolerant of its discomforts²

Blue Ocean Strategy

  • Expected immediate demand from patients intolerant of CPAP
  • Consumer acceptance of our same-price positioning
  • Extensive engagement of Key Opinion Leaders (KOLs)
  • Market education to raise awareness of our novel OSA solution
  • Leverage local manufacturing to reduce OpEx
  • 1
  • 2